Novartis, Pear to develop digital therapies for schizophrenia, MS

2nd March 2018 Uncategorised 0

Novartis and Pear Therapeutics have signed a deal to develop digital therapeutics for patients with schizophrenia and multiple sclerosis.

More: Novartis, Pear to develop digital therapies for schizophrenia, MS
Source: News